{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:20:44Z","timestamp":1791202844113,"version":"4.2.0"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T00:00:00Z","timestamp":1372896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s10096-013-1915-8","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T22:10:04Z","timestamp":1372803004000},"page":"1377-1391","source":"Crossref","is-referenced-by-count":112,"title":["Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment"],"prefix":"10.1007","volume":"32","author":[{"given":"F. P.","family":"Gullo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. de C. O.","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. L. I.","family":"Teodoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J. S.","family":"Mendes-Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Fusco-Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,4]]},"reference":[{"key":"1915_CR1","doi-asserted-by":"crossref","first-page":"547618","DOI":"10.4061\/2011\/547618","volume":"2011","author":"DN Lanjewar","year":"2011","unstructured":"Lanjewar DN (2011) The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of 236 autopsied cases in Mumbai, India. Pathol Res Int 2011:547618","journal-title":"Pathol Res Int"},{"issue":"3","key":"1915_CR2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1590\/S0074-02762009000300019","volume":"104","author":"M Prado","year":"2009","unstructured":"Prado M, Silva MB, Laurenti R, Travassos LR, Taborda CP (2009) Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz 104(3):513\u2013521","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"1915_CR3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 50(3):291\u2013322","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1915_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/13693780601045166","volume":"45","author":"AS Kantarcio\u011flu","year":"2007","unstructured":"Kantarcio\u011flu AS, Boekhout T, De Hoog GS, Theelen B, Y\u00fccel A, Ekmekci TR, Fries BC, Ikeda R, Koslu A, Altas K (2007) Subcutaneous cryptococcosis due to Cryptococcus diffluens in a patient with sporotrichoid lesions case report, features of the case isolate and in vitro antifungal susceptibilities. Med Mycol 45(2):173\u2013181","journal-title":"Med Mycol"},{"issue":"2","key":"1915_CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s15010-007-6142-8","volume":"35","author":"T Khawcharoenporn","year":"2007","unstructured":"Khawcharoenporn T, Apisarnthanarak A, Mundy LM (2007) Non-neoformans cryptococcal infections: a systematic review. Infection 35(2):51\u201358","journal-title":"Infection"},{"issue":"4","key":"1915_CR6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1567-1364.2006.00071.x","volume":"6","author":"SM Levitz","year":"2006","unstructured":"Levitz SM, Specht CA (2006) The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res 6(4):513\u2013524","journal-title":"FEMS Yeast Res"},{"issue":"17","key":"1915_CR7","doi-asserted-by":"crossref","first-page":"14820","DOI":"10.1074\/jbc.M110.177030","volume":"286","author":"J Grechi","year":"2011","unstructured":"Grechi J, Marinho-Carvalho M, Zancan P, Cinelli LP, Gomes AM, Rodrigues ML, Nimrichter L, Sola-Penna M (2011) Glucuronoxylomannan from Cryptococcus neoformans down-regulates the enzyme 6-phosphofructo-1-kinase of macrophages. J Biol Chem 286(17):14820\u201314829","journal-title":"J Biol Chem"},{"issue":"6","key":"1915_CR8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1590\/S0037-86822002000600008","volume":"35","author":"WF Fili\u00fa","year":"2002","unstructured":"Fili\u00fa WF, Wanke B, Ag\u00fcena SM, Vilela VO, Macedo RC, Laz\u00e9ra M (2002) Avian habitats as sources of Cryptococcus neoformans in the city of Campo Grande, Mato Grosso do Sul, Brazil. Rev Soc Bras Med Trop 35(6):591\u2013595","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"1915_CR9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","volume":"31","author":"S Chen","year":"2000","unstructured":"Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, Marriott D, Pfeiffer T, Parr D, Byth K (2000) Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 31(2):499\u2013508","journal-title":"Clin Infect Dis"},{"issue":"49","key":"1915_CR10","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1073\/pnas.0402981101","volume":"101","author":"SE Kidd","year":"2004","unstructured":"Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, Macdougall L, Boekhout T, Kwon-Chung KJ, Meyer W (2004) A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A 101(49):17258\u201317263","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1915_CR11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/597306","volume":"199","author":"EJ Byrnes 3rd","year":"2009","unstructured":"Byrnes EJ 3rd, Bildfell RJ, Frank SA, Mitchell TG, Marr KA, Heitman J (2009) Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis 199(7):1081\u20131086","journal-title":"J Infect Dis"},{"issue":"28","key":"1915_CR12","first-page":"865","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC) (2010) Emergence of Cryptococcus gattii\u2014Pacific Northwest, 2004\u20132010. MMWR Morb Mortal Wkly Rep 59(28):865\u2013868","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"1915_CR13","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/IAI.68.2.832-838.2000","volume":"68","author":"DL Goldman","year":"2000","unstructured":"Goldman DL, Lee SC, Mednick AJ, Montella L, Casadevall A (2000) Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide. Infect Immun 68(2):832\u2013838","journal-title":"Infect Immun"},{"issue":"6","key":"1915_CR14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1462-5822.2008.01128.x","volume":"10","author":"A Jong","year":"2008","unstructured":"Jong A, Wu CH, Shackleford GM, Kwon-Chung KJ, Chang YC, Chen HM, Ouyang Y, Huang SH (2008) Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol 10(6):1313\u20131326","journal-title":"Cell Microbiol"},{"issue":"4","key":"1915_CR15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1590\/S0074-02762012000400004","volume":"107","author":"MS Jesus","year":"2012","unstructured":"Jesus MS, Rodrigues WC, Barbosa G, Trilles L, Wanke B, Laz\u00e9ra MdosS, Silva Md (2012) Cryptococcus neoformans carried by Odontomachus bauri ants. Mem Inst Oswaldo Cruz 107(4):466\u2013469","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"1915_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid0902.020246","volume":"9","author":"W Meyer","year":"2003","unstructured":"Meyer W, Casta\u00f1eda A, Jackson S, Huynh M, Casta\u00f1eda E; IberoAmerican Cryptococcal Study Group. (2003) Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 9(2):189\u2013195","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"1915_CR17","doi-asserted-by":"crossref","first-page":"e37566","DOI":"10.1371\/journal.pone.0037566","volume":"7","author":"C Firacative","year":"2012","unstructured":"Firacative C, Trilles L, Meyer W (2012) MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans\/C. gattii species complex. PLoS One 7(5):e37566","journal-title":"PLoS One"},{"issue":"1","key":"1915_CR18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JCM.41.1.73-77.2003","volume":"41","author":"MM Nishikawa","year":"2003","unstructured":"Nishikawa MM, Lazera MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RC, Bezerra CC, P\u00e9rez MA, Cardarelli P, Wanke B (2003) Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. J Clin Microbiol 41(1):73\u201377","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1915_CR19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0934-8840(11)80305-1","volume":"275","author":"KJ Kwon-Chung","year":"1991","unstructured":"Kwon-Chung KJ (1991) The discovery of creatinine assimilation in Cryptococcus neoformans, and subsequent work on the characterization of the two varieties of C. neoformans. Zentralbl Bakteriol 275(3):390\u2013393","journal-title":"Zentralbl Bakteriol"},{"issue":"5","key":"1915_CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/02681219880000481","volume":"36","author":"LF Passoni","year":"1998","unstructured":"Passoni LF, Wanke B, Nishikawa MM, Laz\u00e9ra MS (1998) Cryptococcus neoformans isolated from human dwellings in Rio de Janeiro, Brazil: an analysis of the domestic environment of AIDS patients with and without cryptococcosis. Med Mycol 36(5):305\u2013311","journal-title":"Med Mycol"},{"issue":"3","key":"1915_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1647\/2009-003.1","volume":"24","author":"G Gonz\u00e1lez-Hein","year":"2010","unstructured":"Gonz\u00e1lez-Hein G, Gonz\u00e1lez-Hein J, D\u00edaz Jarabr\u00e1n MC (2010) Isolation of Cryptococcus neoformans in dry droppings of captive birds in Santiago, Chile. J Avian Med Surg 24(3):227\u2013236","journal-title":"J Avian Med Surg"},{"key":"1915_CR22","doi-asserted-by":"crossref","first-page":"840452","DOI":"10.1155\/2009\/840452","volume":"2009","author":"A Dixit","year":"2009","unstructured":"Dixit A, Carroll SF, Qureshi ST (2009) Cryptococcus gattii: an emerging cause of fungal disease in North America. Interdiscip Perspect Infect Dis 2009:840452","journal-title":"Interdiscip Perspect Infect Dis"},{"issue":"2","key":"1915_CR23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1590\/S0037-86822010000200018","volume":"43","author":"RO Faria","year":"2010","unstructured":"Faria RO, Nascente PdaS, Meinerz AR, Cleff MB, Antunes TdeA, Silveira EdaS, Nobre MdeO, Meireles MC, Mello JR (2010) Occurrence of Cryptococcus neoformans in pigeon excrement in the city of Pelotas, State of Rio Grande do Sul. Rev Soc Bras Med Trop 43(2):198\u2013200","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"1915_CR24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/JCM.01985-10","volume":"49","author":"JN Day","year":"2011","unstructured":"Day JN, Hoang TN, Duong AV, Hong CT, Diep PT, Campbell JI, Sieu TP, Hien TT, Bui T, Boni MF, Lalloo DG, Carter D, Baker S, Farrar JJ (2011) Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1. J Clin Microbiol 49(2):658\u2013664","journal-title":"J Clin Microbiol"},{"issue":"6","key":"1915_CR25","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/JCM.39.6.2348-2350.2001","volume":"39","author":"BM Calvo","year":"2001","unstructured":"Calvo BM, Colombo AL, Fischman O, Santiago A, Thompson L, Lazera M, Telles F, Fukushima K, Nishimura K, Tanaka R, Myiajy M, Moretti-Branchini ML (2001) Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela. J Clin Microbiol 39(6):2348\u20132350","journal-title":"J Clin Microbiol"},{"issue":"4","key":"1915_CR26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1567-1364.2006.00055.x","volume":"6","author":"P Escand\u00f3n","year":"2006","unstructured":"Escand\u00f3n P, S\u00e1nchez A, Mart\u00ednez M, Meyer W, Casta\u00f1eda E (2006) Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia. FEMS Yeast Res 6(4):625\u2013635","journal-title":"FEMS Yeast Res"},{"issue":"3","key":"1915_CR27","first-page":"152","volume":"16","author":"LC Severo","year":"1999","unstructured":"Severo LC, de Mattos Oliveira F, Londero AT (1999) Cryptococcosis due to Cryptococcus neoformans var. gattii in Brazilian patients with AIDS. Report of three cases. Rev Iberoam Micol 16(3):152\u2013154","journal-title":"Rev Iberoam Micol"},{"issue":"9","key":"1915_CR28","doi-asserted-by":"crossref","first-page":"e1002205","DOI":"10.1371\/journal.ppat.1002205","volume":"7","author":"EJ Byrnes 3rd","year":"2011","unstructured":"Byrnes EJ 3rd, Li W, Ren P, Lewit Y, Voelz K, Fraser JA, Dietrich FS, May RC, Chaturvedi S, Chaturvedi V, Heitman J (2011) A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV\/AIDS patients. PLoS Pathog 7(9):e1002205","journal-title":"PLoS Pathog"},{"issue":"2","key":"1915_CR29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3201\/eid1702.101020","volume":"17","author":"L MacDougall","year":"2011","unstructured":"MacDougall L, Fyfe M, Romney M, Starr M, Galanis E (2011) Risk factors for Cryptococcus gattii infection, British Columbia, Canada. Emerg Infect Dis 17(2):193\u2013199","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"1915_CR30","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3201\/eid1810.120068","volume":"18","author":"F Hagen","year":"2012","unstructured":"Hagen F, Colom MF, Swinne D, Tintelnot K, Iatta R, Montagna MT, Torres-Rodriguez JM, Cogliati M, Velegraki A, Burggraaf A, Kamermans A, Sweere JM, Meis JF, Klaassen CH, Boekhout T (2012) Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis 18(10):1618\u20131624","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"1915_CR31","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1128\/AAC.00746-10","volume":"54","author":"F Hagen","year":"2010","unstructured":"Hagen F, Illnait-Zaragozi MT, Bartlett KH, Swinne D, Geertsen E, Klaassen CH, Boekhout T, Meis JF (2010) In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 54(12):5139\u20135145","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1915_CR32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s15010-008-8211-z","volume":"37","author":"A Georgi","year":"2009","unstructured":"Georgi A, Schneemann M, Tintelnot K, Calligaris-Maibach RC, Meyer S, Weber R, Bosshard PP (2009) Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure. Infection 37(4):370\u2013373","journal-title":"Infection"},{"issue":"5","key":"1915_CR33","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/432486","volume":"192","author":"AP Litvintseva","year":"2005","unstructured":"Litvintseva AP, Thakur R, Reller LB, Mitchell TG (2005) Prevalence of clinical isolates of Cryptococcus gattii serotype C among patients with AIDS in Sub-Saharan Africa. J Infect Dis 192(5):888\u2013892","journal-title":"J Infect Dis"},{"issue":"8","key":"1915_CR34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/13693780802124026","volume":"46","author":"HS Randhawa","year":"2008","unstructured":"Randhawa HS, Kowshik T, Chowdhary A, Preeti Sinha K, Khan ZU, Sun S, Xu J (2008) The expanding host tree species spectrum of Cryptococcus gattii and Cryptococcus neoformans and their isolations from surrounding soil in India. Med Mycol 46(8):823\u2013833","journal-title":"Med Mycol"},{"issue":"1","key":"1915_CR35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7705\/biomedica.v31i1.342","volume":"31","author":"C Firacative","year":"2011","unstructured":"Firacative C, Torres G, Rodr\u00edguez MC, Escand\u00f3n P (2011) First environmental isolation of Cryptococcus gattii serotype B, from C\u00facuta, Colombia. Biomedica 31(1):118\u2013123","journal-title":"Biomedica"},{"issue":"6","key":"1915_CR36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1590\/S0074-02762011000600012","volume":"106","author":"LM Martins","year":"2011","unstructured":"Martins LM, Wanke B, Laz\u00e9ra MdosS, Trilles L, Barbosa GG, de Macedo RC, Cavalcanti MdoA, Eul\u00e1lio KD, de Castro JA, da Silva AS, do Nacimento FF, Gouveia VA, do Monte SJ (2011) Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresin, Piau\u00ed (northeastern Brazil). Mem Inst Oswaldo Cruz 106(6):725\u2013730","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"7","key":"1915_CR37","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/JCM.43.7.3548-3550.2005","volume":"43","author":"MF Colom","year":"2005","unstructured":"Colom MF, Fras\u00e9s S, Ferrer C, Jover A, Andreu M, Reus S, S\u00e1nchez M, Torres-Rodr\u00edguez JM (2005) First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain. J Clin Microbiol 43(7):3548\u20133550","journal-title":"J Clin Microbiol"},{"issue":"2\u20133","key":"1915_CR38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12019-003-0012-9","volume":"29","author":"LH McCurdy","year":"2003","unstructured":"McCurdy LH, Morrow JD (2003) Infections due to non-neoformans cryptococcal species. Compr Ther 29(2\u20133):95\u2013101","journal-title":"Compr Ther"},{"issue":"4","key":"1915_CR39","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/JCM.39.4.1608-1611.2001","volume":"39","author":"MF Cheng","year":"2001","unstructured":"Cheng MF, Chiou CC, Liu YC, Wang HZ, Hsieh KS (2001) Cryptococcus laurentii fungemia in a premature neonate. J Clin Microbiol 39(4):1608\u20131611","journal-title":"J Clin Microbiol"},{"issue":"5","key":"1915_CR40","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/714031137","volume":"40","author":"D Averbuch","year":"2002","unstructured":"Averbuch D, Boekhoutt T, Falk R, Engelhard D, Shapiro M, Block C, Polacheck I (2002) Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii. Med Mycol 40(5):479\u2013484","journal-title":"Med Mycol"},{"issue":"5","key":"1915_CR41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1155\/2006\/160451","volume":"13","author":"EM Shankar","year":"2006","unstructured":"Shankar EM, Kumarasamy N, Bella D, Renuka S, Kownhar H, Suniti S, Rajan R, Rao UA (2006) Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS. Can Respir J 13(5):275\u2013278","journal-title":"Can Respir J"},{"issue":"1","key":"1915_CR42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2478\/v10039-009-0014-7","volume":"54","author":"K Furman-Kukli\u0144ska","year":"2009","unstructured":"Furman-Kukli\u0144ska K, Naumnik B, My\u015bliwiec M (2009) Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy\u2014a case report. Adv Med Sci 54(1):116\u2013119","journal-title":"Adv Med Sci"},{"issue":"4","key":"1915_CR43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1348-0421.2001.tb02621.x","volume":"45","author":"T Sugita","year":"2001","unstructured":"Sugita T, Takashima M, Ikeda R, Nakase T, Shinoda T (2001) Intraspecies diversity of Cryptococcus albidus isolated from humans as revealed by sequences of the internal transcribed spacer regions. Microbiol Immunol 45(4):291\u2013297","journal-title":"Microbiol Immunol"},{"issue":"1","key":"1915_CR44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/13693780701541106","volume":"46","author":"R Kano","year":"2008","unstructured":"Kano R, Kitagawat M, Oota S, Oosumi T, Murakami Y, Tokuriki M, Hasegawa A (2008) First case of feline systemic Cryptococcus albidus infection. Med Mycol 46(1):75\u201377","journal-title":"Med Mycol"},{"issue":"4","key":"1915_CR45","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7589\/2011-08-226","volume":"48","author":"S Mcleland","year":"2012","unstructured":"Mcleland S, Duncan C, Spraker T, Wheeler E, Lockhart SR, Gulland F (2012) Cryptococcus albidus infection in a California sea lion (Zalophus californianus). J Wildl Dis 48(4):1030\u20131034","journal-title":"J Wildl Dis"},{"issue":"1","key":"1915_CR46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1745-6673-7-11","volume":"7","author":"DP Leite Jr","year":"2012","unstructured":"Leite DP Jr, Amadio JV, Martins ER, Sim\u00f5es SA, Yamamoto AC, Leal-Santos FA, Takahara DT, Hahn RC (2012) Cryptococcus spp isolated from dust microhabitat in Brazilian libraries. J Occup Med Toxicol 7(1):11","journal-title":"J Occup Med Toxicol"},{"issue":"7","key":"1915_CR47","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","volume":"9","author":"D Sanglard","year":"2009","unstructured":"Sanglard D, Coste A, Ferrari S (2009) Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9(7):1029\u20131050","journal-title":"FEMS Yeast Res"},{"issue":"6","key":"1915_CR48","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/QCO.0b013e3283177f6c","volume":"21","author":"JN Jarvis","year":"2008","unstructured":"Jarvis JN, Dromer F, Harrison TS, Lortholary O (2008) Managing cryptococcosis in the immunocompromised host. Curr Opin Infect Dis 21(6):596\u2013603","journal-title":"Curr Opin Infect Dis"},{"key":"1915_CR49","doi-asserted-by":"crossref","unstructured":"Sloan D, Dlamini S, Paul N, Dedicoat M (2008) Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev (4):CD005647","DOI":"10.1002\/14651858.CD005647.pub2"},{"issue":"1","key":"1915_CR50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1130-1406(06)70012-2","volume":"23","author":"M Catal\u00e1n","year":"2006","unstructured":"Catal\u00e1n M, Montejo JC (2006) Systemic antifungals. Pharmacodynamics and pharmacokinetics. Rev Iberoam Micol 23(1):39\u201349","journal-title":"Rev Iberoam Micol"},{"issue":"3\u20134","key":"1915_CR51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000221854","volume":"21","author":"A Polak","year":"1975","unstructured":"Polak A, Scholer HJ (1975) Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy 21(3\u20134):113\u2013130","journal-title":"Chemotherapy"},{"issue":"1\u20133","key":"1915_CR52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tox.2005.10.020","volume":"219","author":"ER Tr\u00f6sken","year":"2006","unstructured":"Tr\u00f6sken ER, Fischer K, V\u00f6lkel W, Lutz WK (2006) Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC-MS\/MS method for the analysis of estradiol product formation. Toxicology 219(1\u20133):33\u201340","journal-title":"Toxicology"},{"issue":"9312","key":"1915_CR53","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","volume":"359","author":"DP Kontoyiannis","year":"2002","unstructured":"Kontoyiannis DP, Lewis RE (2002) Antifungal drug resistance of pathogenic fungi. Lancet 359(9312):1135\u20131144","journal-title":"Lancet"},{"issue":"11","key":"1915_CR54","first-page":"1129","volume":"42","author":"LC Shao","year":"2007","unstructured":"Shao LC, Sheng CQ, Zhang WN (2007) Recent advances in the study of antifungal lead compounds with new chemical scaffolds. Yao Xue Xue Bao 42(11):1129\u20131136","journal-title":"Yao Xue Xue Bao"},{"issue":"6","key":"1915_CR55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijantimicag.2008.05.023","volume":"32","author":"E Johnson","year":"2008","unstructured":"Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P (2008) Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies. Int J Antimicrob Agents 32(6):511\u2013514","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"1915_CR56","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1128\/IAI.00529-08","volume":"76","author":"A Guerrero","year":"2008","unstructured":"Guerrero A, Fries BC (2008) Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response. Infect Immun 76(9):4322\u20134331","journal-title":"Infect Immun"},{"issue":"2","key":"1915_CR57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1590\/S0037-86822008000200005","volume":"41","author":"PR Silva","year":"2008","unstructured":"Silva PR, Rabelo RA, Terra AP, Teixeira DN (2008) Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital. Rev Soc Bras Med Trop 41(2):158\u2013162","journal-title":"Rev Soc Bras Med Trop"},{"key":"1915_CR58","doi-asserted-by":"crossref","unstructured":"Andrade-Silva L, Ferreira-Paim K, Mora DJ, Silva PR, Andrade AA, Araujo NE, Pedrosa AL, Silva-Vergara ML (2013) Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil. Med Mycol [Epub ahead of print]","DOI":"10.3109\/13693786.2012.761737"},{"key":"1915_CR59","first-page":"19","volume":"18","author":"VT Andriole","year":"1998","unstructured":"Andriole VT (1998) Current and future therapy of invasive fungal infections. Curr Clin Top Infect Dis 18:19\u201336","journal-title":"Curr Clin Top Infect Dis"},{"issue":"4","key":"1915_CR60","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1128\/AAC.01384-07","volume":"52","author":"MT Illnait-Zaragozi","year":"2008","unstructured":"Illnait-Zaragozi MT, Mart\u00ednez GF, Curfs-Breuker I, Fern\u00e1ndez CM, Boekhout T, Meis JF (2008) In vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrob Agents Chemother 52(4):1580\u20131582","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1915_CR61","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/AAC.41.11.2333","volume":"41","author":"GK Abruzzo","year":"1997","unstructured":"Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Pikounis VB, Balkovec JM, Bouffard AF, Dropinski JF, Rosen H, Kropp H, Bartizal K (1997) Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother 41(11):2333\u20132338","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1915_CR62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1130-1406(09)70004-X","volume":"26","author":"A Espinel-Ingroff","year":"2009","unstructured":"Espinel-Ingroff A (2009) Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005\u20132009). Rev Iberoam Micol 26(1):15\u201322","journal-title":"Rev Iberoam Micol"},{"issue":"1","key":"1915_CR63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1368-7646(98)80208-2","volume":"1","author":"NJ White","year":"1998","unstructured":"White NJ (1998) Preventing antimalarial drug resistance through combinations. Drug Resist Updat 1(1):3\u20139","journal-title":"Drug Resist Updat"},{"issue":"Suppl 1","key":"1915_CR64","first-page":"67","volume":"197","author":"JL Rodr\u00edguez Tudela","year":"1997","unstructured":"Rodr\u00edguez Tudela JL (1997) The resistance of opportunistic fungi to antifungals. Rev Clin Esp 197(Suppl 1):67\u201374","journal-title":"Rev Clin Esp"},{"issue":"4","key":"1915_CR65","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1586\/eri.09.18","volume":"7","author":"J Pem\u00e1n","year":"2009","unstructured":"Pem\u00e1n J, Cant\u00f3n E, Espinel-Ingroff A (2009) Antifungal drug resistance mechanisms. Expert Rev Anti Infect Ther 7(4):453\u2013460","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"1915_CR66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1462-5814.2003.00268.x","volume":"5","author":"JD Nosanchuk","year":"2003","unstructured":"Nosanchuk JD, Casadevall A (2003) The contribution of melanin to microbial pathogenesis. Cell Microbiol 5(4):203\u2013223","journal-title":"Cell Microbiol"},{"issue":"4","key":"1915_CR67","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/654813","volume":"202","author":"RA Bryan","year":"2010","unstructured":"Bryan RA, Jiang Z, Howell RC, Morgenstern A, Bruchertseifer F, Casadevall A, Dadachova E (2010) Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection. J Infect Dis 202(4):633\u2013637","journal-title":"J Infect Dis"},{"issue":"4","key":"1915_CR68","doi-asserted-by":"crossref","first-page":"509","DOI":"10.18388\/abp.1995_4904","volume":"42","author":"P Marichal","year":"1995","unstructured":"Marichal P, Vanden Bossche H (1995) Mechanisms of resistance to azole antifungals. Acta Biochim Pol 42(4):509\u2013516","journal-title":"Acta Biochim Pol"},{"issue":"Pt 2","key":"1915_CR69","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/00221287-143-2-405","volume":"143","author":"D Sanglard","year":"1997","unstructured":"Sanglard D, Ischer F, Monod M, Bille J (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143(Pt 2):405\u2013416","journal-title":"Microbiology"},{"issue":"6B","key":"1915_CR70","first-page":"4173","volume":"25","author":"MJ Ferreira","year":"2005","unstructured":"Ferreira MJ, Gy\u00e9m\u00e1nt N, Madureira AM, Tanaka M, Ko\u00f3s K, Didziapetris R, Moln\u00e1r J (2005) The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line. Anticancer Res 25(6B):4173\u20134178","journal-title":"Anticancer Res"},{"issue":"2","key":"1915_CR71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1130-1406(08)70027-5","volume":"25","author":"A Espinel-Ingroff","year":"2008","unstructured":"Espinel-Ingroff A (2008) Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev Iberoam Micol 25(2):101\u2013106","journal-title":"Rev Iberoam Micol"},{"issue":"1","key":"1915_CR72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/AAC.49.1.57-70.2005","volume":"49","author":"BC Monk","year":"2005","unstructured":"Monk BC, Niimi K, Lin S, Knight A, Kardos TB, Cannon RD, Parshot R, King A, Lun D, Harding DR (2005) Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrob Agents Chemother 49(1):57\u201370","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1915_CR73","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00051-08","volume":"22","author":"RD Cannon","year":"2009","unstructured":"Cannon RD, Lamping E, Holmes AR, Niimi K, Baret PV, Keniya MV, Tanabe K, Niimi M, Goffeau A, Monk BC (2009) Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22(2):291\u2013321, Table of Contents","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"1915_CR74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/187152606784112164","volume":"6","author":"R Prasad","year":"2006","unstructured":"Prasad R, Gaur NA, Gaur M, Komath SS (2006) Efflux pumps in drug resistance of Candida. Infect Disord Drug Targets 6(2):69\u201383","journal-title":"Infect Disord Drug Targets"},{"issue":"11","key":"1915_CR75","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1128\/AAC.47.11.3653-3656.2003","volume":"47","author":"L Rodero","year":"2003","unstructured":"Rodero L, Mellado E, Rodriguez AC, Salve A, Guelfand L, Cahn P, Cuenca-Estrella M, Davel G, Rodriguez-Tudela JL (2003) G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrob Agents Chemother 47(11):3653\u20133656","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1915_CR76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1567-1364.2006.00128.x","volume":"7","author":"AM Almeida","year":"2007","unstructured":"Almeida AM, Matsumoto MT, Baeza LC, de Oliveira E Silva RB, Kleiner AA, Melhem MdeS, Mendes Giannini MJ; Laboratory Group on Cryptococcosis (2007) Molecular typing and antifungal susceptibility of clinical sequential isolates of Cryptococcus neoformans from Sao Paulo State, Brazil. FEMS Yeast Res 7(1):152\u2013164","journal-title":"FEMS Yeast Res"},{"issue":"8","key":"1915_CR77","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/AAC.01630-08","volume":"53","author":"C Sheng","year":"2009","unstructured":"Sheng C, Miao Z, Ji H, Yao J, Wang W, Che X, Dong G, L\u00fc J, Guo W, Zhang W (2009) Three-dimensional model of lanosterol 14 alpha-demethylase from Cryptococcus neoformans: active-site characterization and insights into azole binding. Antimicrob Agents Chemother 53(8):3487\u20133495","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1915_CR78","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.39.11.2378","volume":"39","author":"D Sanglard","year":"1995","unstructured":"Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 39(11):2378\u20132386","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1915_CR79","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1128\/AAC.41.10.2229","volume":"41","author":"P Marichal","year":"1997","unstructured":"Marichal P, Vanden Bossche H, Odds FC, Nobels G, Warnock DW, Timmerman V, Van Broeckhoven C, Fay S, Mose-Larsen P (1997) Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother 41(10):2229\u20132237","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1915_CR80","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/AAC.45.10.2676-2684.2001","volume":"45","author":"S Perea","year":"2001","unstructured":"Perea S, L\u00f3pez-Ribot JL, Kirkpatrick WR, McAtee RK, Santill\u00e1n RA, Mart\u00ednez M, Calabrese D, Sanglard D, Patterson TF (2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 45(10):2676\u20132684","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1915_CR81","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1128\/AAC.49.11.4608-4615.2005","volume":"49","author":"P Vandeputte","year":"2005","unstructured":"Vandeputte P, Larcher G, Berg\u00e8s T, Renier G, Chabasse D, Bouchara JP (2005) Mechanisms of azole resistance in a clinical isolate of Candida tropicalis. Antimicrob Agents Chemother 49(11):4608\u20134615","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1915_CR82","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1128\/AAC.47.3.1120-1124.2003","volume":"47","author":"TM Diaz-Guerra","year":"2003","unstructured":"Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Rodriguez-Tudela JL (2003) A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 47(3):1120\u20131124","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1915_CR83","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/AAC.47.2.577-581.2003","volume":"47","author":"PA Mann","year":"2003","unstructured":"Mann PA, Parmegiani RM, Wei SQ, Mendrick CA, Li X, Loebenberg D, DiDomenico B, Hare RS, Walker SS, McNicholas PM (2003) Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase. Antimicrob Agents Chemother 47(2):577\u2013581","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1915_CR84","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/JCM.02330-07","volume":"46","author":"G Garcia-Effron","year":"2008","unstructured":"Garcia-Effron G, Dilger A, Alcazar-Fuoli L, Park S, Mellado E, Perlin DS (2008) Rapid detection of triazole antifungal resistance in Aspergillus fumigatus. J Clin Microbiol 46(4):1200\u20131206","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1915_CR85","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/AAC.00295-09","volume":"53","author":"E Sionov","year":"2009","unstructured":"Sionov E, Chang YC, Garraffo HM, Kwon-Chung KJ (2009) Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob Agents Chemother 53(7):2804\u20132815","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1915_CR86","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1128\/AAC.00153-10","volume":"54","author":"A Varma","year":"2010","unstructured":"Varma A, Kwon-Chung KJ (2010) Heteroresistance of Cryptococcus gattii to fluconazole. Antimicrob Agents Chemother 54(6):2303\u20132311","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1915_CR87","doi-asserted-by":"crossref","first-page":"e1000848","DOI":"10.1371\/journal.ppat.1000848","volume":"6","author":"E Sionov","year":"2010","unstructured":"Sionov E, Lee H, Chang YC, Kwon-Chung KJ (2010) Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog 6(4):e1000848","journal-title":"PLoS Pathog"},{"issue":"8","key":"1915_CR88","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.43.8.1856","volume":"43","author":"P Mondon","year":"1999","unstructured":"Mondon P, Petter R, Amalfitano G, Luzzati R, Concia E, Polacheck I, Kwon-Chung KJ (1999) Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob Agents Chemother 43(8):1856\u20131861","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1915_CR89","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3201\/eid1407.080122","volume":"14","author":"M Bovers","year":"2008","unstructured":"Bovers M, Hagen F, Kuramae EE, Hoogveld HL, Dromer F, St-Germain G, Boekhout T (2008) AIDS patient death caused by novel Cryptococcus neoformans \u00d7 C. gattii hybrid. Emerg Infect Dis 14(7):1105\u20131108","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"1915_CR90","doi-asserted-by":"crossref","first-page":"e1000850","DOI":"10.1371\/journal.ppat.1000850","volume":"6","author":"EJ Byrnes 3rd","year":"2010","unstructured":"Byrnes EJ 3rd, Li W, Lewit Y, Ma H, Voelz K, Ren P, Carter DA, Chaturvedi V, Bildfell RJ, May RC, Heitman J (2010) Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 6(4):e1000850","journal-title":"PLoS Pathog"},{"issue":"11","key":"1915_CR91","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/AAC.01115-12","volume":"56","author":"A Espinel-Ingroff","year":"2012","unstructured":"Espinel-Ingroff A, Aller AI, Canton E, Casta\u00f1\u00f3n-Olivares LR, Chowdhary A, Cordoba S, Cuenca-Estrella M, Fothergill A, Fuller J, Govender N, Hagen F, Illnait-Zaragozi MT, Johnson E, Kidd S, Lass-Fl\u00f6rl C, Lockhart SR, Martins MA, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Pfaller MA, Schell WA, St-Germain G, Trilles L, Turnidge J (2012) Cryptococcus neoformans\u2013Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother 56(11):5898\u20135906","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1915_CR92","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/JCM.01271-10","volume":"48","author":"HS Chong","year":"2010","unstructured":"Chong HS, Dagg R, Malik R, Chen S, Carter D (2010) In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype. J Clin Microbiol 48(11):4115\u20134120","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1915_CR93","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.01747-08","volume":"47","author":"MA Pfaller","year":"2009","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Bijie H, Dzierzanowska D, Klimko NN, Letscher-Bru V, Lisalova M, Muehlethaler K, Rennison C, Zaidi M; Global Antifungal Surveillance Group (2009) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 47(1):117\u2013123","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1915_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.39.1.1","volume":"39","author":"JH Rex","year":"1995","unstructured":"Rex JH, Rinaldi MG, Pfaller MA (1995) Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 39(1):1\u20138","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1915_CR95","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.fgb.2009.08.002","volume":"47","author":"J Morschh\u00e4user","year":"2010","unstructured":"Morschh\u00e4user J (2010) Regulation of multidrug resistance in pathogenic fungi. Fungal Genet Biol 47(2):94\u2013106","journal-title":"Fungal Genet Biol"},{"issue":"4","key":"1915_CR96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12281-010-0035-5","volume":"4","author":"LR Martinez","year":"2010","unstructured":"Martinez LR, Fries BC (2010) Fungal biofilms: relevance in the setting of human disease. Curr Fungal Infect Rep 4(4):266\u2013275","journal-title":"Curr Fungal Infect Rep"},{"issue":"6","key":"1915_CR97","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF01708112","volume":"22","author":"A Bach","year":"1996","unstructured":"Bach A (1996) Central venous catheter infections. Intensive Care Med 22(6):613","journal-title":"Intensive Care Med"},{"issue":"11","key":"1915_CR98","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1128\/IAI.00995-06","volume":"74","author":"LR Martinez","year":"2006","unstructured":"Martinez LR, Casadevall A (2006) Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system. Infect Immun 74(11):6118\u20136123","journal-title":"Infect Immun"},{"issue":"6","key":"1915_CR99","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/jac\/dkf049","volume":"49","author":"G Ramage","year":"2002","unstructured":"Ramage G, Bachmann S, Patterson TF, Wickes BL, L\u00f3pez-Ribot JL (2002) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49(6):973\u2013980","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1915_CR100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13693780500107554","volume":"43","author":"PK Mukherjee","year":"2005","unstructured":"Mukherjee PK, Zhou G, Munyon R, Ghannoum MA (2005) Candida biofilm: a well-designed protected environment. Med Mycol 43(3):191\u2013208","journal-title":"Med Mycol"},{"issue":"10","key":"1915_CR101","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1128\/IAI.73.10.6350-6362.2005","volume":"73","author":"LR Martinez","year":"2005","unstructured":"Martinez LR, Casadevall A (2005) Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 73(10):6350\u20136362","journal-title":"Infect Immun"},{"issue":"1","key":"1915_CR102","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","volume":"9","author":"TF Mah","year":"2001","unstructured":"Mah TF, O\u2019Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9(1):34\u201339","journal-title":"Trends Microbiol"},{"issue":"4","key":"1915_CR103","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10096-012-1774-8","volume":"32","author":"R Aguiar Cordeiro de","year":"2013","unstructured":"de Aguiar Cordeiro R, Mour\u00e3o CI, Rocha MF, de Farias Marques FJ, Teixeira CE, de Oliveira Miranda DF, Neto LV, Brilhante RS, de Jesus Pinheiro Gomes Bandeira T, Sidrim JJ (2013) Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B. Eur J Clin Microbiol Infect Dis 32(4):557\u2013564","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"22","key":"1915_CR104","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1128\/AEM.01953-12","volume":"78","author":"EJ Robertson","year":"2012","unstructured":"Robertson EJ, Wolf JM, Casadevall A (2012) EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans. Appl Environ Microbiol 78(22):7977\u20137984","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"1915_CR105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biomaterials.2009.09.087","volume":"31","author":"LR Martinez","year":"2010","unstructured":"Martinez LR, Mihu MR, Han G, Frases S, Cordero RJ, Casadevall A, Friedman AJ, Friedman JM, Nosanchuk JD (2010) The use of chitosan to damage Cryptococcus neoformans biofilms. Biomaterials 31(4):669\u2013679","journal-title":"Biomaterials"},{"issue":"2","key":"1915_CR106","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/13693780903136879","volume":"48","author":"RK Pettit","year":"2010","unstructured":"Pettit RK, Repp KK, Hazen KC (2010) Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents. Med Mycol 48(2):421\u2013426","journal-title":"Med Mycol"},{"issue":"3","key":"1915_CR107","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1130-1406(07)70040-2","volume":"24","author":"G Quind\u00f3s","year":"2007","unstructured":"Quind\u00f3s G, Del Palacio A, Pont\u00f3n J (2007) Present and future of voriconazole in the treatment of invasive mycoses: the inseparable binomial diagnosis-treatment. Rev Iberoam Micol 24(3):179\u2013180","journal-title":"Rev Iberoam Micol"},{"issue":"1","key":"1915_CR108","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1130-1406(09)70008-7","volume":"26","author":"G Quind\u00f3s","year":"2009","unstructured":"Quind\u00f3s G, Villar-Vidal M, Eraso E (2009) Activity of micafungin against Candida biofilms. Rev Iberoam Micol 26(1):49\u201355","journal-title":"Rev Iberoam Micol"},{"issue":"4","key":"1915_CR109","first-page":"247","volume":"31","author":"GGF Nascimento","year":"2000","unstructured":"Nascimento GGF, Locatelli J, Freitas PC, Silva GL (2000) Atividade de extratos vegetais e fitof\u00e1rmacos sobre bact\u00e9rias resistentes a antibi\u00f3ticos. Braz J Microbiol 31(4):247\u2013256","journal-title":"Braz J Microbiol"},{"issue":"6","key":"1915_CR110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1590\/S0074-02762005000600001","volume":"100","author":"LA Basso","year":"2005","unstructured":"Basso LA, da Silva LH, Fett-Neto AG, de Azevedo WF Jr, Moreira IdeS, Palma MS, Calixto JB, Astolfi Filho S, dos Santos RR, Soares MB, Santos DS (2005) The use of biodiversity as source of new chemical entities against defined molecular targets for treatment of malaria, tuberculosis, and T-cell mediated diseases\u2014a review. Mem Inst Oswaldo Cruz 100(6):475\u2013506","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"1915_CR111","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6882-6-2","volume":"6","author":"JJ Rojas","year":"2006","unstructured":"Rojas JJ, Ochoa VJ, Ocampo SA, Mu\u00f1oz JF (2006) Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: a possible alternative in the treatment of non-nosocomial infections. BMC Complement Altern Med 6:2","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"1915_CR112","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jep.2006.12.005","volume":"111","author":"MC Cruz","year":"2007","unstructured":"Cruz MC, Santos PO, Barbosa AM Jr, de M\u00e9lo DL, Alviano CS, Antoniolli AR, Alviano DS, Trindade RC (2007) Antifungal activity of Brazilian medicinal plants involved in popular treatment of mycoses. J Ethnopharmacol 111(2):409\u2013412","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"1915_CR113","doi-asserted-by":"crossref","first-page":"e39782","DOI":"10.1371\/journal.pone.0039782","volume":"7","author":"F Zhu","year":"2012","unstructured":"Zhu F, Ma XH, Qin C, Tao L, Liu X, Shi Z, Zhang CL, Tan CY, Chen YZ, Jiang YY (2012) Drug discovery prospect from untapped species: indications from approved natural product drugs. PLoS One 7(7):e39782","journal-title":"PLoS One"},{"key":"1915_CR114","doi-asserted-by":"crossref","first-page":"340787","DOI":"10.1155\/2012\/340787","volume":"2012","author":"FP Gullo","year":"2012","unstructured":"Gullo FP, Sardi JC, Santos VA, Sangalli-Leite F, Pitangui NS, Rossi SA, de Paula E Silva AC, Soares LA, Silva JF, Oliveira HC, Furlan M, Silva DH, Bolzani VS, Mendes-Giannini MJ, Fusco-Almeida AM (2012) Antifungal activity of maytenin and pristimerin. Evid Based Complement Alternat Med 2012:340787","journal-title":"Evid Based Complement Alternat Med"},{"issue":"9","key":"1915_CR115","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.ejmech.2011.07.019","volume":"46","author":"L Carvalho Tavares de","year":"2011","unstructured":"de Carvalho Tavares L, Johann S, Maria de Almeida Alves T, Guerra JC, Maria de Souza-Fagundes E, Cisalpino PS, Bortoluzzi AJ, Caramori GF, de Mattos Piccoli R, Braibante HTS, Braibante MEF, Pizzolatti MG (2011) Quinolinyl and quinolinyl N-oxide chalcones: synthesis, antifungal and cytotoxic activities. Eur J Med Chem 46(9):4448\u20134456","journal-title":"Eur J Med Chem"},{"key":"1915_CR116","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1472-6882-11-33","volume":"11","author":"RS Nondo","year":"2011","unstructured":"Nondo RS, Mbwambo ZH, Kidukuli AW, Innocent EM, Mihale MJ, Erasto P, Moshi MJ (2011) Larvicidal, antimicrobial and brine shrimp activities of extracts from Cissampelos mucronata and Tephrosia villosa from coast region, Tanzania. BMC Complement Altern Med 11:33","journal-title":"BMC Complement Altern Med"},{"issue":"3","key":"1915_CR117","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.fitote.2011.12.023","volume":"83","author":"N Rangkadilok","year":"2012","unstructured":"Rangkadilok N, Tongchusak S, Boonhok R, Chaiyaroj SC, Junyaprasert VB, Buajeeb W, Akanimanee J, Raksasuk T, Suddhasthira T, Satayavivad J (2012) In vitro antifungal activities of longan (Dimocarpus longan Lour.) seed extract. Fitoterapia 83(3):545\u2013553","journal-title":"Fitoterapia"},{"issue":"4","key":"1915_CR118","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00253-011-3303-6","volume":"91","author":"N Tocci","year":"2011","unstructured":"Tocci N, Simonetti G, D\u2019Auria FD, Panella S, Palamara AT, Valletta A, Pasqua G (2011) Root cultures of Hypericum perforatum subsp. angustifolium elicited with chitosan and production of xanthone-rich extracts with antifungal activity. Appl Microbiol Biotechnol 91(4):977\u2013987","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"1915_CR119","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jac\/41.1.127","volume":"41","author":"CJ Clancy","year":"1998","unstructured":"Clancy CJ, Nguyen MH (1998) The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fusariosis. J Antimicrob Chemother 41(1):127\u2013130","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1915_CR120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","volume":"79","author":"TF Patterson","year":"2000","unstructured":"Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, Rinaldi MG, Stevens DA, Graybill JR (2000) Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 79(4):250\u2013260","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1915_CR121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52(1):1","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1915_CR122","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","volume":"48","author":"MD Johnson","year":"2004","unstructured":"Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH (2004) Combination antifungal therapy. Antimicrob Agents Chemother 48(3):693\u2013715","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1915_CR123","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/AAC.49.7.2994-2996.2005","volume":"49","author":"C Serena","year":"2005","unstructured":"Serena C, Fern\u00e1ndez-Torres B, Pastor FJ, Trilles L, Laz\u00e9ra MdosS, Nolard N, Guarro J (2005) In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrob Agents Chemother 49(7):2994\u20132996","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1915_CR124","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1248\/bpb.28.541","volume":"28","author":"Y Han","year":"2005","unstructured":"Han Y, Lee JH (2005) Berberine synergy with amphotericin B against disseminated candidiasis in mice. Biol Pharm Bull 28(3):541\u2013544","journal-title":"Biol Pharm Bull"},{"issue":"11","key":"1915_CR125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.phymed.2007.08.004","volume":"14","author":"Y Han","year":"2007","unstructured":"Han Y (2007) Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans. Phytomedicine 14(11):733\u2013738","journal-title":"Phytomedicine"},{"issue":"4","key":"1915_CR126","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","volume":"30","author":"MS Saag","year":"2000","unstructured":"Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE (2000) Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 30(4):710\u2013718","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1915_CR127","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/AAC.47.10.3361-3364.2003","volume":"47","author":"P Schwarz","year":"2003","unstructured":"Schwarz P, Dromer F, Lortholary O, Dannaoui E (2003) In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother 47(10):3361\u20133364","journal-title":"Antimicrob Agents Chemother"},{"key":"1915_CR128","unstructured":"Leite FS (2010) Perfil fenot\u00edpico e de express\u00e3o de prote\u00ednas de Cryptococcus neoformans ap\u00f3s tratamento com subst\u00e2ncias obtidas da planta Pterogyne nitens. An\u00e1lises Cl\u00ednicas, Faculdade de Ci\u00eancias Farmac\u00eauticas, UNESP, Araraquara"},{"key":"1915_CR129","unstructured":"Suzano FR (2012) Estudo da atividade antif\u00fangica de extratos e fra\u00e7\u00f5es purificadas das plantas Serjania erecta radlk e Eclipta alba em linhagens de Cryptococcus neoformans. Biotecnologia, Universidade de Ribeir\u00e3o Preto, Ribeir\u00e3o Preto"},{"issue":"1\u20132","key":"1915_CR130","first-page":"80","volume":"48","author":"A Ahmad","year":"2012","unstructured":"Ahmad A, Khan A, Manzoor N (2012) Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole. Eur J Pharm Sci 48(1\u20132):80\u201386","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"1915_CR131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/psc.914","volume":"14","author":"T Cabras","year":"2008","unstructured":"Cabras T, Longhi R, Secundo F, Nocca G, Conti S, Polonelli L, Fanali C, Inzitari R, Petruzzelli R, Messana I, Castagnola M, Vitali A (2008) Structural and functional characterization of the porcine proline-rich antifungal peptide SP-B isolated from salivary gland granules. J Pept Sci 14(3):251\u2013260","journal-title":"J Pept Sci"},{"issue":"2","key":"1915_CR132","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","volume":"12","author":"HA Gallis","year":"1990","unstructured":"Gallis HA, Drew RH, Pickard WW (1990) Amphotericin B: 30 years of clinical experience. Rev Infect Dis 12(2):308\u2013329","journal-title":"Rev Infect Dis"},{"issue":"4","key":"1915_CR133","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/AAC.42.4.899","volume":"42","author":"KV Clemons","year":"1998","unstructured":"Clemons KV, Stevens DA (1998) Comparison of fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis. Antimicrob Agents Chemother 42(4):899\u2013902","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"1915_CR134","first-page":"816","volume":"34","author":"SF Xu","year":"2011","unstructured":"Xu SF, Wang P, Liang ZX, Sun JP, Zhao XW, Li AM, Chen LA (2011) Investigation of inflammatory responses of pulmonary microvascular endothelial cells induced by lipopolysaccharide and mechanism. Zhonghua Jie He He Hu Xi Za Zhi 34(11):816\u2013820","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"issue":"10","key":"1915_CR135","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1016\/j.biomaterials.2009.12.042","volume":"31","author":"H Wang","year":"2010","unstructured":"Wang H, Xu K, Liu L, Tan JP, Chen Y, Li Y, Fan W, Wei Z, Sheng J, Yang YY, Li L (2010) The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. Biomaterials 31(10):2874\u20132881","journal-title":"Biomaterials"},{"issue":"2","key":"1915_CR136","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3314\/jjmm.48.97","volume":"48","author":"T Yaguchi","year":"2007","unstructured":"Yaguchi T, Takizawa K, Taguchi H, Tanaka R, Kubota T, Kubota Y, Kubota M, Fukushima K (2007) Antifungal activity of the novel adduct, GX-95, of silver with nanometer-scale particles to peptidic hydrolysates from collagen. Nihon Ishinkin Gakkai Zasshi 48(2):97\u2013100","journal-title":"Nihon Ishinkin Gakkai Zasshi"},{"issue":"8","key":"1915_CR137","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/AAC.00121-07","volume":"51","author":"BB Fuchs","year":"2007","unstructured":"Fuchs BB, Tegos GP, Hamblin MR, Mylonakis E (2007) Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob Agents Chemother 51(8):2929\u20132936","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1915_CR138","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1751-1097.2010.00868.x","volume":"87","author":"BM Soares","year":"2011","unstructured":"Soares BM, Alves OA, Ferreira MV, Amorim JC, Sousa GR, Silveira LdeB, Prates RA, Avila TV, Baltazar LdeM, de Souza DdaG, Santos DA, Modolo LV, Cisalpino PS, Pinotti M (2011) Cryptococcus gattii: in vitro susceptibility to photodynamic inactivation. Photochem Photobiol 87(2):357\u2013364","journal-title":"Photochem Photobiol"},{"issue":"2","key":"1915_CR139","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1751-1097.2011.01055.x","volume":"88","author":"GB Rodrigues","year":"2012","unstructured":"Rodrigues GB, Primo FL, Tedesco AC, Braga GU (2012) In vitro photodynamic inactivation of Cryptococcus neoformans melanized cells with chloroaluminum phthalocyanine nanoemulsion. Photochem Photobiol 88(2):440\u2013447","journal-title":"Photochem Photobiol"},{"issue":"2","key":"1915_CR140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1469-0691.2011.03741.x","volume":"18","author":"C Antachopoulos","year":"2012","unstructured":"Antachopoulos C, Walsh TJ (2012) Immunotherapy of Cryptococcus infections. Clin Microbiol Infect 18(2):126\u2013133","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"1915_CR141","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.4049\/jimmunol.1103455","volume":"189","author":"SE Hardison","year":"2012","unstructured":"Hardison SE, Herrera G, Young ML, Hole CR, Wozniak KL, Wormley FL Jr (2012) Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J Immunol 189(8):4060\u20134068","journal-title":"J Immunol"},{"issue":"2","key":"1915_CR142","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2249.1996.14723.x","volume":"104","author":"K Kawakami","year":"1996","unstructured":"Kawakami K, Tohyama M, Xie Q, Saito A (1996) IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin Exp Immunol 104(2):208\u2013214","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1915_CR143","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/AAC.45.3.686-689.2001","volume":"45","author":"KV Clemons","year":"2001","unstructured":"Clemons KV, Lutz JE, Stevens DA (2001) Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice. Antimicrob Agents Chemother 45(3):686\u2013689","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"1915_CR144","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1128\/IAI.66.10.4994-5000.1998","volume":"66","author":"K Decken","year":"1998","unstructured":"Decken K, K\u00f6hler G, Palmer-Lehmann K, Wunderlin A, Mattner F, Magram J, Gately MK, Alber G (1998) Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun 66(10):4994\u20135000","journal-title":"Infect Immun"},{"issue":"3","key":"1915_CR145","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/AAC.38.3.460","volume":"38","author":"KV Clemons","year":"1994","unstructured":"Clemons KV, Brummer E, Stevens DA (1994) Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob Agents Chemother 38(3):460\u2013464","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"1915_CR146","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","volume":"26","author":"JN Jarvis","year":"2012","unstructured":"Jarvis JN, Meintjes G, Rebe K, Williams GN, Bicanic T, Williams A, Schutz C, Bekker LG, Wood R, Harrison TS (2012) Adjunctive interferon-\u03b3 immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial. AIDS 26(9):1105\u20131113","journal-title":"AIDS"},{"issue":"2","key":"1915_CR147","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<643::AID-IMMU643>3.0.CO;2-E","volume":"29","author":"MH Qureshi","year":"1999","unstructured":"Qureshi MH, Zhang T, Koguchi Y, Nakashima K, Okamura H, Kurimoto M, Kawakami K (1999) Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans. Eur J Immunol 29(2):643\u2013649","journal-title":"Eur J Immunol"},{"issue":"9","key":"1915_CR148","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1128\/IAI.65.9.3594-3599.1997","volume":"65","author":"T Zhang","year":"1997","unstructured":"Zhang T, Kawakami K, Qureshi MH, Okamura H, Kurimoto M, Saito A (1997) Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun 65(9):3594\u20133599","journal-title":"Infect Immun"},{"issue":"5","key":"1915_CR149","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/1061186X.2012.685474","volume":"20","author":"AA Khan","year":"2012","unstructured":"Khan AA, Jabeen M, Chauhan A, Owais M (2012) Vaccine potential of cytosolic proteins loaded fibrin microspheres of Cryptococcus neoformans in BALB\/c mice. J Drug Target 20(5):453\u2013466","journal-title":"J Drug Target"},{"issue":"10","key":"1915_CR150","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1086\/503431","volume":"42","author":"A Casadevall","year":"2006","unstructured":"Casadevall A (2006) The third age of antimicrobial therapy. Clin Infect Dis 42(10):1414\u20131416","journal-title":"Clin Infect Dis"},{"issue":"10","key":"1915_CR151","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","volume":"42","author":"J Pachl","year":"2006","unstructured":"Pachl J, Svoboda P, Jacobs F, Vandewoude K, van der Hoven B, Spronk P, Masterson G, Malbrain M, Aoun M, Garbino J, Takala J, Drgona L, Burnie J, Matthews R; Mycograb Invasive Candidiasis Study Group (2006) A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis 42(10):1404\u20131413","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1915_CR152","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.4049\/jimmunol.166.3.2100","volume":"166","author":"CP Taborda","year":"2001","unstructured":"Taborda CP, Casadevall A (2001) Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments. J Immunol 166(3):2100\u20132107","journal-title":"J Immunol"},{"issue":"7","key":"1915_CR153","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.4049\/jimmunol.161.7.3557","volume":"161","author":"J Mukherjee","year":"1998","unstructured":"Mukherjee J, Kozel TR, Casadevall A (1998) Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies. J Immunol 161(7):3557\u20133568","journal-title":"J Immunol"},{"issue":"5","key":"1915_CR154","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/IAI.69.5.3410-3412.2001","volume":"69","author":"AL Rosas","year":"2001","unstructured":"Rosas AL, Nosanchuk JD, Casadevall A (2001) Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infect Immun 69(5):3410\u20133412","journal-title":"Infect Immun"},{"issue":"11","key":"1915_CR155","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/IAI.60.11.4534-4541.1992","volume":"60","author":"J Mukherjee","year":"1992","unstructured":"Mukherjee J, Scharff MD, Casadevall A (1992) Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun 60(11):4534\u20134541","journal-title":"Infect Immun"},{"issue":"3","key":"1915_CR156","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/AAC.38.3.580","volume":"38","author":"J Mukherjee","year":"1994","unstructured":"Mukherjee J, Zuckier LS, Scharff MD, Casadevall A (1994) Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob Agents Chemother 38(3):580\u2013587","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1915_CR157","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1128\/AAC.39.7.1398","volume":"39","author":"J Mukherjee","year":"1995","unstructured":"Mukherjee J, Feldmesser M, Scharff MD, Casadevall A (1995) Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy. Antimicrob Agents Chemother 39(7):1398\u20131405","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"1915_CR158","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","volume":"49","author":"RA Larsen","year":"2005","unstructured":"Larsen RA, Pappas PG, Perfect J, Aberg JA, Casadevall A, Cloud GA, James R, Filler S, Dismukes WE (2005) Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother 49(3):952\u2013958","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1915_CR159","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1128\/AAC.00473-11","volume":"56","author":"Z Jiang","year":"2012","unstructured":"Jiang Z, Bryan RA, Morgenstern A, Bruchertseifer F, Casadevall A, Dadachova E (2012) Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent mice. Antimicrob Agents Chemother 56(1):552\u2013554","journal-title":"Antimicrob Agents Chemother"},{"key":"1915_CR160","doi-asserted-by":"crossref","unstructured":"Marongiu B, Piras A, Porcedda S, Falconieri D, Maxia A, Frau MA, Gon\u00e7alves MJ, Cavaleiro C, Salgueiro L (2012) Isolation of the volatile fraction from Apium graveolens L. (Apiaceae) by supercritical carbon dioxide extraction and hydrodistillation: chemical composition and antifungal activity. Nat Prod Res [Epub ahead of print]","DOI":"10.1080\/14786419.2012.725402"},{"issue":"3","key":"1915_CR161","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1248\/cpb.60.377","volume":"60","author":"N Fukuyama","year":"2012","unstructured":"Fukuyama N, Shibuya M, Orihara Y (2012) Antimicrobial polyacetylenes from Panax ginseng hairy root culture. Chem Pharm Bull (Tokyo) 60(3):377\u2013380","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"12","key":"1915_CR162","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.3390\/molecules16129827","volume":"16","author":"JH Lago","year":"2011","unstructured":"Lago JH, Souza ED, Mariane B, Pascon R, Vallim MA, Martins RC, Baroli AA, Carvalho BA, Soares MG, dos Santos RT, Sartorelli P (2011) Chemical and biological evaluation of essential oils from two species of Myrtaceae\u2014Eugenia uniflora L. and Plinia trunciflora (O. Berg) Kausel. Molecules 16(12):9827\u20139837","journal-title":"Molecules"},{"issue":"24","key":"1915_CR163","doi-asserted-by":"crossref","first-page":"12864","DOI":"10.1021\/jf2035466","volume":"59","author":"KD Patel","year":"2011","unstructured":"Patel KD, Scarano FJ, Kondo M, Hurta RA, Neto CC (2011) Proanthocyanidin-rich extracts from cranberry fruit (Vaccinium macrocarpon Ait.) selectively inhibit the growth of human pathogenic fungi Candida spp. and Cryptococcus neoformans. J Agric Food Chem 59(24):12864\u201312873","journal-title":"J Agric Food Chem"},{"issue":"14","key":"1915_CR164","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/14786419.2010.502532","volume":"25","author":"N Fukuyama","year":"2011","unstructured":"Fukuyama N, Ino C, Suzuki Y, Kobayashi N, Hamamoto H, Sekimizu K, Orihara Y (2011) Antimicrobial sesquiterpenoids from Laurus nobilis L. Nat Prod Res 25(14):1295\u20131303","journal-title":"Nat Prod Res"},{"issue":"3","key":"1915_CR165","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.foodchem.2012.06.077","volume":"135","author":"CS Funari","year":"2012","unstructured":"Funari CS, Gullo FP, Napolitano A, Carneiro RL, Mendes-Giannini MJ, Fusco-Almeida AM, Piacente S, Pizza C, Silva DH (2012) Chemical and antifungal investigations of six Lippia species (Verbenaceae) from Brazil. Food Chem 135(3):2086\u20132094","journal-title":"Food Chem"},{"issue":"5","key":"1915_CR166","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1590\/S0102-695X2010005000017","volume":"20","author":"LO Regasini","year":"2010","unstructured":"Regasini LO, Pivatto M, Scorzoni L, Benaducci T, Fusco-Almeida AM, Mendes-Giannini MJS, Barreiro EJ, Silva DHS, da Silva Bolzani V (2010) Antimicrobial activity of Pterogyne nitens Tul., Fabaceae, against opportunistic fungi. Rev Bras Farmacogn 20(5):706\u2013711","journal-title":"Rev Bras Farmacogn"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-1915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-013-1915-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-013-1915-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T17:58:17Z","timestamp":1715623097000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-013-1915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,4]]},"references-count":166,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["1915"],"URL":"https:\/\/doi.org\/10.1007\/s10096-013-1915-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,4]]}}}